SmartQuit Program for Smoking Cessation

Study of SmartQuit, a Smartphone-Based Smoking Cessation Program

This trial investigates how well a smartphone-based smoking cessation program called SmartQuit works to help patients stop smoking. SmartQuit is an smartphone application-based smoking cessation program that includes a defined program consisting of interactive evidence-based exercises for dealing more effectively with urges to smoke, a place to track desired behaviors, personalized plans for quitting, and a certificate of completion once the recommended program components are completed. SmartQuit may help patients quit smoking, lower healthcare costs and reduce premature tobacco-related deaths.

Study Overview

• Status: Completed
• Conditions: Cigarette Smoking-Related Carcinoma; Tobacco-Related Carcinoma
• Intervention / Treatment: Other: Survey Administration; Behavioral: SmartQuit Smoking and Tobacco Cessation Program

Detailed Description

OUTLINE:

Patients use the SmartQuit program to learn and practice skill modules as often as they wish over 6 months.

• Study Type: Interventional
• Enrollment (Actual): 99
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Washington
    • Seattle, Washington, United States, 98109
      • Fred Hutch/University of Washington Cancer Consortium

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Smokes at least five cigarettes daily for at least past 12 months
• Wants to quit in the next 30 days
• Interested in learning skills to quit smoking
• Resides in United States (US)
• Has at least daily access to their own smartphone
• Knows how to login and download a smartphone application from their smartphone
• Willing and able to read in English
• Not participating in other smoking cessation interventions (including our other intervention studies)
• Must be an employee of a company who is participating in recruitment
• Willing to complete one follow-up survey
• Provide email, phone, and mailing address

Study Plan

How is the study designed?

Design Details

• Primary Purpose: PREVENTION
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Prevention (SmartQuit); Patients use the SmartQuit program to learn and practice skill modules as often as they wish over 6 months.	Other: Survey Administration; Ancillary studies; Behavioral: SmartQuit Smoking and Tobacco Cessation Program; Use SmartQuit program; Other Names: 2Morrow; SmartQuit

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of participants with 7-day cigarette smoking cessation at 2 months.	No smoking at all in the past 7 or more days (7-day point prevalence quit rate).	At 2 month follow-up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
24-hour point prevalence quit rate		At 2 month follow-up
Change in number of cigarettes smoked per day		At 2 month follow-up
Number of intentional 24-hour quit attempts		At 2 month follow-up
Change in readiness to quit	Differences in a participant's readiness to quit will be assessed by comparing their responses to the baseline survey readiness to quit questions with their responses to the 2 month follow-up survey	At 2 month follow-up
Nicotine dependence level	Participants will share their nicotine dependence level via survey at their 2 month follow-up	At 2 month follow-up
Number of times logged into the application	Will be assessed via 2 month follow-up survey	At 2 month follow-up
Time spent on the application	Will be assessed via 2 month follow-up survey	At 2 month follow-up
Participant satisfaction with the application	Will be assessed via 2 month follow-up survey	At 2 month follow-up
Participant opinion of the usefulness of the application for quitting smoking	Will be assessed via 2 month follow-up survey	At 2 month follow-up

Collaborators and Investigators

• Sponsor: Fred Hutchinson Cancer Center
• Collaborators: Life Sciences Discovery Fund

Study record dates

Study Major Dates

• Study Start (ACTUAL): October 22, 2014
• Primary Completion (ACTUAL): May 31, 2015
• Study Completion (ACTUAL): August 11, 2015

Study Registration Dates

• First Submitted: August 6, 2020
• First Submitted That Met QC Criteria: August 10, 2020
• First Posted (ACTUAL): August 12, 2020

Study Record Updates

• Last Update Posted (ACTUAL): August 12, 2020
• Last Update Submitted That Met QC Criteria: August 10, 2020
• Last Verified: August 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms by Histologic Type; Neoplasms; Neoplasms, Glandular and Epithelial; Carcinoma
• Other Study ID Numbers: RG1001139; NCI-2020-05658 (REGISTRY: NCI / CTRP); 8287 (OTHER: Fred Hutch/University of Washington Cancer Consortium)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No